Amicar 500 mg/1

Amicar Tablet is a product of Xanodyne Pharmaceuticals

Group: Approved Amino Acids

Name: Amicar

Dosage: Tablet

Strength: 500 mg/1

Route: Oral

Pharmaceutical company : Xanodyne Pharmaceuticals

You can also find other alternative products such as : Amicar (250 mg/1mL) from XANODYNE PHARMACEUTICALS, INC. Amicar (500 mg/1) from Clover Pharmaceuticals Corp. Amicar - Syr 250mg/ml (250 mg) from Wyeth Ayerst Canada Inc. Amicar Inj 250mg/ml (250 mg) from Lederle Cyanamid Canada Inc. Amicar - Tab, 500mg (500 mg) from Wyeth Ltd. Amicar (250 mg/1mL) from XANODYNE PHARMACEUTICALS, INC. Amicar (1000 mg/1) from Clover Pharmaceuticals Corp. Amicar (1000 mg/1) from Xanodyne Pharmaceuticals Amicar (0.25 g/1mL) from Xanodyne Pharmaceuticals Amicar (500 mg/1) from Avera McKennan Hospital Amicar (500 mg/1) from Avera McKennan Hospital Amicar (0.25 g/1mL) from Clover Pharmaceuticals Corp. Amicar (500 mg/1) from Clover Pharmaceuticals Corp. Amicar (500 mg/1) from Xanodyne Pharmaceuticals Amicar (500 mg/1) from Xanodyne Pharmaceuticals Amicar (500 mg/1) from Clover Pharmaceuticals Corp.

Indication: For use in the treatment of excessive postoperative bleeding.

Category:

  • Acids, Acyclic
  • Amino Acids
  • Amino Acids, Peptides, and Proteins
  • Aminocaproates
  • Antifibrinolytic Agents
  • Blood and Blood Forming Organs
  • Caproates
  • Coagulants
  • Decreased Fibrinolysis
  • Fatty Acids
  • Fatty Acids, Volatile
  • Fibrin Modulating Agents
  • Hematologic Agents
  • Hemostatics
  • Lipids
  • Food Interactions; Take without regard to meals.

    Aminocaproic Acid Definition:
    An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.

    More Amicar 500 mg/1

    Aminocaproic Acid Injection Rx

    Therapeutic indications Bleeding disorders


    Neonates..Indications for Aminocaproic Acid Injection: Bleeding associated with fibrinolysis.. Pregnancy (Cat..


    AMICAR TABLETS Rx

    Therapeutic indications Bleeding disorders


    Neonates.. See Also: AMICAR ORAL SOLUTION Aminocaproic Acid Injection Pharmacological Class: Hemostatic.. Interactions: Avoid concomitant Factor IX complex or Anti-inhibitor Coagulant concentrates; may increase thrombosis risk..


    Amicar Solution

    Therapeutic indications Consult your pharmacist or physician

    gov/medwatch..List Amicar Solution side effects by likelihood and severity..
    What should I know regarding pregnancy, nursing and administering Amicar Solution to children or the elderly?**Interactions**Consult your pharmacist or physician..Keep a list of all your medications with you, and share the list with your doctor and pharmacist..


    AMICAR ORAL SOLUTION Rx

    Therapeutic indications Bleeding disorders


    Indications for AMICAR ORAL SOLUTION: Bleeding associated with fibrinolysis.. Interactions: Avoid concomitant Factor IX complex or Anti-inhibitor Coagulant concentrates; may increase thrombosis risk.. Avoid rapid IV administration..


    AMICAR ORAL SOLUTION Rx

    Therapeutic indications Bleeding disorders


    See Also: AMICAR TABLETS Aminocaproic Acid Injection Pharmacological Class: Hemostatic..Indications for AMICAR ORAL SOLUTION: Bleeding associated with fibrinolysis.. Adult: Initially 5g during 1st hour, then 1g/hour for 8 hours or until bleeding is controlled..


    Amicar

    Therapeutic indications This medication is used to help control bleeding due to a condition where your blood does not clot the way it normally should (fibrinolysis)

    If any of these effects last or get worse, tell your doctor or pharmacist promptly..List Amicar side effects by likelihood and severity..In the US -Call your doctor for medical advice about side effects..
    Talk to your pharmacist for more details..This medication may interfere with certain lab tests, possibly causing false test results.. Consult your doctor before breast-feeding..


    Other drugs that have exactly the same effects, dosage, intended use, side effects, route of administration, risks, safety, and strength as Aminocaproic Acid

    Name Pharmaceutical
    Aminocaproic Acid 0.25 g/1mLVersa Pharm Incorporated
    Aminocaproic Acid 500 mg/1Versa Pharm Incorporated
    Aminocaproic Acid 0.25 g/1mLVersa Pharm Incorporated
    Aminocaproic Acid 250 mg/1mLAmerican Regent
    Aminocaproic Acid 500 mg/1Versa Pharm Incorporated

    Drug mixture that contained Aminocaproic Acid

    Name Pharmaceutical
    Solmeet Paste, dentifriceSolbin Co., Ltd
    28tak Gum Care Tooth Paste, dentifriceElmeditec Co.,Ltd
    Solmeet Paste, dentifriceSolbin Co., Ltd
    Solmeet Paste, dentifriceSolbin Co., Ltd
    Solmeet Paste, dentifriceSolbin Co., Ltd
    Relief and Nature Toothpast E Jasmine Mint Paste, dentifriceNature Republic Co., Ltd.
    Exoden White Tooth PasteLifeon Corp.
    Exoden White Tooth PasteLifeon Corp.
    BAMBOO SALT Eunganggo Jook Yeom Toothpaste PasteLg Household & Health Care Ltd.
    BAMBOO SALT Eunganggo Jook Yeom PasteLg Household & Health Care Ltd.

    Over-the-counter(OTC) drugs

    Name Pharmaceutical
    Solco Platino Iondenti Tooth 0.02 g/100gSolco Biomedical Co., Ltd.

    Effects of Amicar 500 mg/1 by reaction with another drug or drugs

  • Aminocaproic Acid may increase the thrombogenic activities of Hydrogen peroxide.
  • Aminocaproic Acid may increase the thrombogenic activities of Alpha-1-proteinase inhibitor.
  • Aminocaproic Acid may increase the thrombogenic activities of Pantothenic acid.
  • Aminocaproic Acid may increase the thrombogenic activities of Trenonacog alfa.
  • Tretinoin may increase the thrombogenic activities of Aminocaproic Acid.
  • Aminocaproic Acid may increase the thrombogenic activities of Rusalatide acetate.
  • Aminocaproic Acid may increase the thrombogenic activities of Kallidinogenase.
  • Aminocaproic Acid may increase the thrombogenic activities of Thrombin Alfa.
  • Aminocaproic Acid may increase the thrombogenic activities of Phylloquinone.
  • Aminocaproic Acid may increase the thrombogenic activities of Kallidinogenase.
  • Aminocaproic Acid may increase the thrombogenic activities of Phylloquinone.
  • Aminocaproic Acid may increase the thrombogenic activities of Damoctocog alfa pegol.
  • Aminocaproic Acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
  • Aminocaproic Acid may increase the thrombogenic activities of Coagulation Factor XIII A-Subunit (Recombinant).
  • Aminocaproic Acid may increase the thrombogenic activities of Damoctocog alfa pegol.
  • Aminocaproic Acid may increase the thrombogenic activities of Calcium cation.
  • Aminocaproic Acid may increase the thrombogenic activities of Calcium Phosphate.
  • Aminocaproic Acid may increase the thrombogenic activities of Kallidinogenase.
  • Aminocaproic Acid may increase the thrombogenic activities of Calcium threonate.
  • Aminocaproic Acid may increase the thrombogenic activities of Factor XIII (human).